Allyx Therapeutics, Inc. — Form D
Allyx Therapeutics, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-10. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-10
- Form: D
- Accession: 0001865257-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 11
- Date of first sale: 2023-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473164
Issuer
- Name: Allyx Therapeutics, Inc.
- CIK: 0001865257
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 555 Long Wharf Drive Floor 11, NEW HAVEN, CT, 06511
- Phone: (908) 432-2845
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Robert A Bettigole | Director | New Haven, CT |
| Stephen Bloch | Director | Parsippany, NJ |
| Paul P Fonteyne | Director | Westport, CT |
| Gregory P Ho | Director | New York, NY |
| Stephen Strittmatter | Director | New Haven, CT |
| Stephen Bloch | Executive Officer | Parsippany, NJ |
| Timothy P Siegert | Executive Officer | Hamden, CT |
| Paul Fonteyne | Director | New Haven, CT |
| Paul Fonteyne | Related Person | New Haven, CT |
| Stephen Bloch | Related Person | Parsippany, NJ |
| Stephen Strittmatter | Executive Officer | New Haven, CT |
| Stephen Strittmatter | Related Person | New Haven, CT |
| Gregory P Ho | Related Person | New York, NY |
| Robert A Bettigole | Related Person | New Haven, CT |
| Jennifer A Gabler | Executive Officer | New Haven, CT |
| Timothy A Siegert | Executive Officer | New Haven, CT |
| Timothy Siegert | Related Person | New Haven, CT |
| Kevin L. Rakin | Related Person | Westport, CT |
Other filings by this issuer (3)
More